Coronavirüs Nedir, Nasıl Korunabiliriz?

Abstract

Coronavirusler onyıllardır viral üst solunum yolu enfeksiyonuna neden olan virüs ailelerinden biri olmakla birlikte Aralık 2019’dan beri giderek artan şekilde ölümcül hastalığa yol açarak dünya gündemine girmiştir. COVID-19 denen antite halihazırda dünyada 90.000’e yakın insanı etkilemiş ve 3000’den fazla ölüme yol açmıştır. Hastalığın yayılmasını durdurmak için olguların hızla tanınıp izole edilmesi, gereken durumlarda yerleşim birimlerinde karantina uygulamaları gerekmekle birlikte en önemli önlemler bireylerin farkındalığının artırılarak kendi kendine alınacak önlemler olacaktır. Bilim kuruluşları, sağlık birimleri ve devlet kurumlarının koordine çalışması ile salgın sona erecektir.

Keywords

• Coronavirus,COVID-19,Viral pandemi

What is Coronaviruses, and How Can We Protect Ourselves?

Abstract

Coronaviruses are among viral groups known to have caused common cold. However, they are in the center of global agenda after the rates of potentially fatal infection soared starting in December 2019. The entity called COVID-19 has already inflicted nearly 90.000 people globally and killed more than 3000 in many countries. While important precautions include expedient isolation of the sick individuals, quarantining people in a defined area if necessary, the most important measures are advancement of public awareness on the issue and self-protection against the disease. Finally, coordinated actions of scientific world, healthcare institutions and public administration will pave the way to end the disease. 

Keywords

• Coronavirus,COVID-19,Viral pandemics

References

1. 1. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. DOI:10.1056/NEJMoa2001017.
2. 2. Novel coronavirus (2019-nCoV): Situation report – 5, 25 January 2020. Geneva: World Health Organization, 2020 (https://www .who .int/ docs/ default -source/coronaviruse/ situation-reports/20200125 -sitrep-5-2019-ncov.pdf).
3. 3. Corman V, Bleicker T, Brünink S, et al. Diagnostic detection of Wuhan coronavirus 2019 by real-time RT-PCR. Geneva: World Health Organization, January 13, 2020 (https://www .who .int/docs/ default -source/coronaviruse/ wuhan -virus-assay-v1991527e5122341d99287a1b17c111902.pdf).
4. 4. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. January 24, 2020 (https://www .thelancet .com/ journals/ lancet/article/ PIIS0140 -6736(20)30183 -5/fulltext).
5. 5. Phan LT, et al. Importation and Human-to-Human Transmission of a Novel Coronavirus in Vietnam. NEJM; January 28, 2020.
6. 6. World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected. Interim guidance; 28 January 2020 WHO/nCoV/Clinical/2020.2
7. 7. Riviello ED, Kiviri W, Twagirumugabe T, et al. Hospital Incidence and Outcomes of the Acute Respiratory Distress Syndrome Using the Kigali Modification of the Berlin Definition. Am J Respir Crit Care Med 2016;193:52-9.
8. 8. Khemani RG, Smith LS, Zimmerman JJ, Erickson S, Pediatric Acute Lung Injury Consensus Conference Group. Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference. Pediatr Crit Care Med 2015;16:S23-40.

9. 9. Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016;315:801-10.
10. 10. Davis AL, Carcillo JA, Aneja RK, et al. American College of Critical Care Medicine Clinical Practice Parameters for Hemodynamic Support of Pediatric and Neonatal Septic Shock. Crit Care Med 2017;45:1061-93.
11. 11. Advice on the use of masks the community, during home care and in health care settings in the context of the novel coronavirus (2019-nCoV) outbreak Interim guidance 29 January 2020 WHO/nCov/IPC_Masks/2020.1
12. 12. Tang B, et al. An updated estimation of the risk of transmission of the novel coronavirus (2019-nCov). Infectious Disease Modelling 5 (2020) 248e255.
13. 13. Imai, N., Cori, A., Dorigatti, I., Baguelin, M., Donnelly, C. A., Riley, S., et al. (2020). Report 3: Transmissibility of 2019-nCoV. Available at: https://www.imperial. ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/Imperial-2019-nCoV-transmissibility.pdf.
14. 14. Kucharski, A., Russell, T., Diamond, C., CMMID nCoV working group, Funk, S., & Eggo, R. (2020). Analysis of early transmission of 2019-nCoV and implications for outbreaks in new locations. Available at: https://cmmid.github.io/ncov/wuhan_early_dynamics/index.html.
15. 15. Wu, J. T., Leung, K., & Leung, G. M. (2020). Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: A modelling study. The Lancet. https://doi.org/10.1016/S0140-6736(20)30260-9.
16. 16. Kruse RL. Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China. Version 2. F1000Res. 2020; 9: 72. Published online 2020 Feb 7. doi: 10.12688/f1000research.22211.2
17. 17. Facial Hairstyles and Filtering Facepiece Respirators. CDC. https://www.cdc.gov/niosh/npptl/pdfs/FacialHairWmask11282017-508.pdf